The development of broad-spectrum antiviral medical countermeasures to treat viral hemorrhagic fevers caused by natural or weaponized virus infections
The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) began development of a broad-spectrum antiviral countermeasure against deliberate use of high-consequence viral hemorrhagic fevers (VHFs) in 2016. The effort featured comprehensive preclinical...
Saved in:
Main Authors: | Mark R. Hickman (Author), David L. Saunders (Author), Catherine A. Bigger (Author), Christopher D. Kane (Author), Patrick L. Iversen (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The development of broad-spectrum antiviral medical countermeasures to treat viral hemorrhagic fevers caused by natural or weaponized virus infections.
by: Mark R Hickman, et al.
Published: (2022) -
Broad spectrum antiviral activity of favipiravir (T-705): protection from highly lethal inhalational Rift Valley Fever.
by: Amy L Caroline, et al.
Published: (2014) -
dsRNA as broad-spectrum antiviral therapeutics
by: Congfei Xu
Published: (2022) -
Quercetin as an antiviral weapon-A review
by: Ramen Kalita, et al.
Published: (2021) -
The role of platelets in the pathogenesis of viral hemorrhagic fevers.
by: Juan C Zapata, et al.
Published: (2014)